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ABSTRACT
Sgm (Sisomicin-gentamicin methyltransferase) from
antibiotic-producing bacterium Micromonospora
zionensis is an enzyme that confers resistance to
aminoglycosides like gentamicin and sisomicin by
specifically methylating G1405 in bacterial 16S
rRNA. Sgm belongs to the aminoglycoside resis-
tance methyltransferase (Arm) family of enzymes
that have been recently found to spread by horizon-
tal gene transfer among disease-causing bacteria.
Structural characterization of Arm enzymes is the
key to understand their mechanism of action and
to develop inhibitors that would block their
activity. Here we report the structure of Sgm in
complex with cofactors S-adenosylmethionine
(AdoMet) and S-adenosylhomocysteine (AdoHcy) at
2.0 and 2.1A ˚ resolution, respectively, and results
of mutagenesis and rRNA footprinting, and
protein-substrate docking. We propose the mecha-
nism of methylation of G1405 by Sgm and compare
it with other m
7G methyltransferases, revealing a
surprising diversity of active sites and binding
modes for the same basic reaction of RNA modifi-
cation. This analysis can serve as a stepping stone
towards developing drugs that would specifically
block the activity of Arm methyltransferases and
thereby re-sensitize pathogenic bacteria to
aminoglycoside antibiotics.
INTRODUCTION
A substantial number of potent and widely used antibi-
otics inhibit the bacterial cell growth by interfering with
the essential cellular process of translation (1). From early
cross-linking and chemical footprinting experiments it has
been learned that antibiotics bind to functionally impor-
tant parts of the ribosome, such as the peptidyl transferase
center, the peptide exit tunnel and the GTPase segment in
the 50S subunit, or to the decoding and tRNA-binding
sites in the 30S subunit. With the advances in ribosome
crystallography many of the atomic aspects have been
revealed that oﬀer a detailed view of diﬀerent snapshots
in protein synthesis, as well as of the interaction of
ribosomal antibiotics with the ribosome. We now know
that the ribosomal RNA is responsible both for the enzy-
matic properties of the ribosome and for most of the
contacts with the antibiotics (2).
Many antibiotic-producing bacteria protect themselves
from the toxic eﬀects of antibiotics by employing enzymes
*To whom correspondence should be addressed. J. Sivaraman. Tel: +65 6516 1163; Fax: +65 6779 2489; Email: dbsjayar@nus.edu.sg
Correspondence may also be addressed to Gordana Maravic ´ -Vlahovic ˇ ek. Tel: +385 1 639 4448; Fax: +385 1 639 4400; Email: gordana@pharma.hr
Correspondence may also be addressed to Janusz M. Bujnicki. Tel: +48 22 597 0750; Fax: +48 22 597 0715; Email: iamb@genesilico.pl
4120–4132 Nucleic Acids Research, 2010, Vol. 38, No. 12 Published online 1 March 2010
doi:10.1093/nar/gkq122
 The Author(s) 2010. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.that add a methyl group to speciﬁc ribonucleotides in
antibiotic-binding sites of the ribosome, thereby disrupt-
ing the antibiotic binding without much interference with
other functions of the ribosome (2). Sgm (Sisomicin-
gentamicin methylase) is a methyltransferase found in
Micromonospora zionensis that produces the antibiotic
G-52 (6-N-methyl-sisomicin) (3). Sgm methylates
G1405 in 16S rRNA to m
7G, thereby rendering the
ribosome resistant to 4, 6-disubstituted deoxystreptamine
aminoglycosides, which include gentamicins and
kanamycins (4,5).
Sgm belongs to the Arm (aminoglycoside resistance
MTase) family, whose members share the same substrate
speciﬁcity (5). Genes encoding members of this protein
family have been isolated not only in antibiotic producers
but also found to spread among human pathogens
cultured from nosocomial infections and animal isolates,
including Pseudomonas aeruginosa (6), Klebsiella
pneumoniae (7) and Escherichia coli (7,8).
The objective of this study is to examine the relationship
between Arm enzymes found in bacteria that produce
antibiotics and those that emerged in resistant pathogens,
as well as to make comparisons between active sites of
diﬀerent enzymes that introduce the m
7G modiﬁcation
in RNA. Thus far, we have made theoretical predictions
of the Sgm structure and identiﬁed amino-acid residues
responsible for catalysis of the methylation reaction (9).
As a continuation of our eﬀorts to understand the rela-
tionship between the structure and modes of action of
antibiotic related MTases, we have solved the crystal
structure of Sgm in complex with its cofactors AdoMet
and AdoHcy at 2.0 and 2.1A ˚ resolutions respectively. We
have also carried out structure-guided mutagenesis, iso-
thermal titration calorimetry and protein–RNA footprint-
ing to develop a model of Sgm–rRNA interactions and
explain its mechanism of m
7G1405 methylation in 16S
rRNA. These ﬁndings can be extended to other
members of Arm family and facilitate the synthesis of
inhibitors to incapacitate the resistance of the pathogens.
MATERIALS AND METHODS
Mutagenesis, expression and puriﬁcation
Cloning of the sgm gene into pET-25b (+) vector with the
addition of N-terminal non-cleavable (His)6 tag, as well as
alanine mutagenesis of residues D156, D182 and R108
were carried out as described previously (9). The con-
structs were co-transformed along with pGroESL into
the strain BL21 (DE3) of E. coli for protein expression.
The E. coli cells were cultured in 1l LB medium at 37 C
until the A600 nm reached 0.5–0.6. The culture was
induced with 150mM IPTG and continued to grow at
20 C overnight. Cells were harvested by centrifugation
(9000 g, 30min, 4 C), and the pellet was resuspended
in the 40ml of lysis buﬀer [50mM HEPES sodium pH
8.0, 250mM NaCl, 10% glycerol, 0.5% Triton X 100,
10mM b-mercaptoethanol (BME), 1 protease inhibitor
tablet (Roche) and 10ml of benzonase nuclease
(Novagen)].
After sonication the cell lysate was centrifuged at
17000rpm for 30min at 4 C (JA-25.50 ﬁxed angle rotor,
Beckman Coulter centrifuge). The supernatant was
allowed to bind to the talon beads (charged with cobalt)
for an hour at 4 C and was subsequently washed twice
with wash buﬀer (50mM HEPES sodium pH 8.0,
250mM NaCl, 10% glycerol, 10mM BME and 5mM
imidazole pH 8.0). Finally the protein was eluted in two
steps using the Buﬀer A (50mM HEPES sodium pH 8.0,
250mM NaCl, 10% glycerol, 10mM BME, 100mM
imidazole pH 8.0) and Buﬀer B (50mM HEPES sodium
pH 8.0, 250mM NaCl, 10% glycerol, 10mM BME and
200mM imidazole pH 8.0). The eluted protein was loaded
onto a size exclusion column (Superdex 200, GE
Healthcare) equilibrated with the buﬀer containing
50mM HEPES sodium pH 8.0, 250mM NaCl, 10%
glycerol, 10mM BME and 10mM MgCl2. The eluted
Sgm was concentrated up to 9mg/ml. Since we did not
obtain structure solution using molecular replacement
method we proceeded with the SelMet protein to
perform the Multi-wavelength Anomalous Dispersion
(MAD) experiment. A similar protocol was adopted to
purify the selenomethionine (SelMet) labeled Sgm using
the LeMaster medium (10).
Isothermal titration calorimetry (ITC)
For ITC experiments the Sgm in a buﬀer consisting of
50mM HEPES sodium pH 8.0, 250mM NaCl, 10%
glycerol, 10mM BME and 10mM MgCl2 was titrated
against S-adenosylmethionine (AdoMet/AdoHcy, MP
Biomedicals) solution prepared by dissolving the appro-
priate amount of AdoMet in the same buﬀer as the
protein. The ITC experiments were carried out using
VP-ITC calorimeter (Microcal, LLC) at 20 C using
0.02–0.07mM protein in the sample cell and 2–5mM
AdoMet/AdoHcy in the injector. All samples were
thoroughly degassed and centrifuged. Injection volumes
of 8–10ml per injection were used for diﬀerent experiments
and for each experiment; the heat of dilution for the ligand
was measured. To restore the baseline, successive injec-
tions were separated by at least 4min. The ITC data
was analyzed by a single site ﬁtting model using Origin
7.0 (OriginLab Corp.) software.
Crystallization and data collection
Puriﬁed Sgm (0.3mM) was complexed with 5mM
of the cofactors S-adenosylmethionine (AdoMet) /
S-adenosylhomocysteine (AdoHcy) [1:17 (Sgm: AdoMet/
AdoHcy)]. Crystallization trials were carried out at room
temperature by hanging-drop vapor-diﬀusion method
using crystallization screens from Hampton Research
(Aliso Viejo, CA, USA) and Jena Bioscience screens
(Jena, Germany). Initially crystals of Sgm–cofactor
complexes were obtained from the Index Screen
(Hampton Screen) (11). Subsequently these conditions
were optimized to obtain the diﬀraction quality crystals.
The best crystals were obtained by mixing 1ml of Sgm–
cofactor complex with 1ml crystallization solution (0.2M
ammonium acetate, 0.1M Tris, pH 8.5, 25% w/v PEG
3350, 0.1M phenol for Sgm–AdoHcy complex; 30%
Nucleic Acids Research, 2010,Vol.38, No. 12 4121PEG 5000 MME, 0.1M sodium MES, pH 6.5, 0.2M
ammonium sulphate for Sgm–AdoMet complex) and
were grown up to 5days.
Prior to data collection, crystals were brieﬂy soaked in a
cryoprotectant consisting of the reservoir solution supple-
mented with 25% glycerol and ﬂash cooled in a N2 cold
stream (100K). A complete MAD data set was collected
for both Sgm–cofactor complexes at the beamline X8C,
NSLS, Brookhaven National Laboratory using a
Quantum4-CCD detector (Area Detector Systems Corp
Poway, CA, USA) to 2.1 and 2.0A ˚ resolutions for Sgm–
AdoHcy and Sgm–AdoMet complexes respectively. All
the datasets were processed and scaled using the
program HKL2000 (12). The crystallographic statistics
are provided in Table 1.
Structure solution and reﬁnement
All the four expected selenium sites in the asymmetric unit
of both Sgm complexes were located by the program
SOLVE (13). The initial phases were further developed
by RESOLVE (14), and the overall ﬁgure of merit was
improved to 0.65 for both Sgm complexes, which made
it possible to build automatically over 90% of the
molecule. The remaining parts of the model were built
manually using the program COOT (15). Alternating
cycles of model building and reﬁnement using the
program CNS (16) with appropriate entries were made
in the dictionaries for AdoMet and AdoHcy. The ﬁnal
model for Sgm–AdoHcy reﬁned to 2.1A ˚ resolution with
an R-factor of 0.20 (Rfree=0.26), while the model for
Sgm–AdoMet reﬁned to 2.0A ˚ resolution with an
R-factor of 0.23 (Rfree=0.28). The PROCHECK (17)
analysis of both Sgm complexes does not show any
residue in the disallowed regions of Ramachandran plot
(Table 1). However, it shows one residue (Thr128) in the
generously allowed regions. This residue is well deﬁned in
the electron density map and it is not in the vicinity of the
active-site region.
Isolation of 30S ribosomal subunits
Escherichia coli BL21 (DE3) cells were grown at 37 Ci n
LB medium to an early log phase at an OD450 of 0.4–0.5.
Bacteria were collected by centrifugation at low speed
(3500 g) and resuspended in low magnesium buﬀer
TM1N (50mM Tris–HCl pH 7.5, 1mM MgCl2, 100mM
NH4Cl). The suspension was lysed by sonication and cell
debris was removed by two centrifugation cycles at
20000 g for 10min. The lysate was loaded onto a
5–30% sucrose gradient in TM1N buﬀer followed by
centrifugation at 18000rpm for 18h in a Beckman
SW-28.1 rotor. Gradient fractions were collected and the
absorbance of the fractions was measured at 260nm. 30S
subunit containing fractions were pooled and dialyzed
three times in 1l of TM1N buﬀer for 2-h periods. The
subunits were pelleted by centrifugation at 40000rpm
Table 1. Crystallographic data and reﬁnement statistics
Data set AdoMet AdoHcy
Peak Inﬂection Peak Inﬂection Remote
Cell parameters (A ˚ , )
Space group
a=36.45,
b=68.36,
c=52.15,
 =93.21
P21
a=36.53,
b=68.41,
c=52.22,
 =93.23
P21
a=36.09,
b=68.89,
c=52.20,
 =93.47
P21
a=36.10,
b=68.92,
c=52.20,
 =93.4
P21
a=36.11,
b=68.94,
c=52.23,
 =93.45
P21
Data collection
Resolution range (A ˚ ) 50–2.0 50–1.8 50–2.1 50–2.2 50–2.2
Wavelength (A ˚ ) 0.9790 0.9798 0.9785 0.9798 0.9600
Observed reﬂections >1  108159 158872 113081 98437 98745
Unique reﬂections 32440 23067 29340 25555 25575
Completeness (%) 97.1 98.3 99.9 100 100
Overall (I/ I) 13.9 12.9 11.4 10.5 9.9
Rsym
a (%) 0.08 0.15 0.07 0.09 0.09
Reﬁnement and quality
b
Rwork
c (no. of reﬂections) 0.23 (28102) 0.20 (24835)
Rfree
d (no. of reﬂections) 0.28 (2403) 0.26 (1679)
RMSD bond lengths (A ˚ ) 0.006 0.006
RMSD bond angles( ) 1.4 1.4
Average B-factors
e (A ˚ 2)
Main chain 28.65 21.36
Side chain 30.91 23.61
Ramachandran plot
Most favored regions (%) 90.7 90.7
Additional allowed regions (%) 8.8 8.8
Generously allowed regions (%) 0.4 0.4
Disallowed regions (%) 0.0 0.0
aRsym= |Ii–<I>|/|Ii| where Ii is the intensity of the ith measurement, and <I> is the mean intensity for that reﬂection.
bReﬂections with I>  was used in the reﬁnement.
cRwork=|Fobs–Fcalc|/|Fobs| where Fcalc and Fobs are the calculated and observed structure factor amplitudes, respectively.
dRfree=as for Rwork, but for 5% of the total reﬂections chosen at random and omitted from reﬁnement.
eIndividual B-factor reﬁnements were calculated.
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TM1N buﬀer.
Chemical probing of 30S subunit–Sgm complex
An amount of 10pmol 30S ribosomal subunits were
incubated with a 2-fold molar excess of Sgm
methyltransferase and 1mM AdoHcy in either modiﬁca-
tion buﬀer A (50mM HEPES–KOH, pH 8.0, 10mM
MgCl2, 100mM KCl, 5mM DTT) or B (200mM
HEPES–KOH, pH 7.8, 10mM MgCl2, 100mM KCl) for
30min at 37 Ci n5 0 ml reaction mixtures. Control reac-
tions contained no AdoHcy. The complexes were modiﬁed
with either 50ml of CMCT (18) [1-cyclohexyl-3-
(2-morpholinoethyl)carbodiimide metho-p-toluene
sulfonate; 42mg/ml in modiﬁcation buﬀer A] for 10min
at 37 C, or 1ml of DEPC (19) (diethyl pyrocarbonate) for
1h at room temperature. RNA was puriﬁed immediately
with RNeasy mini kit (Qiagen), RNA cleanup protocol.
The chemical modiﬁcations were monitored by primer
extension analysis using AMV reverse transcriptase
(Finnzymes) and 50-Cy5 modiﬁed deoxyoligonucleotides
complementary to the 16S rRNA sequences 1459–1479,
939–955 and 817–833 [(20), as modiﬁcation of the
protocol described in (21)]. The cDNA products of
primer extension reactions were separated on 9%
polyacrylamide sequencing gel and visualised on Storm
imager (GE Healthcare).
Molecular docking
Macromolecular rigid-body docking of the Sgm crystal
structure to the E. coli 30S ribosome subunit (PDB IDs:
2AVY and 2I2P) (22), and to a 33-nt long fragment
comprising the target nucleoside G1405 (residues 1401–
1434 of 16S rRNA) was carried out using GRAMM
v1.03 (23). Additional docking was carried out for a
fragment of helix 44 comprising nt 1401–1420 and 1480–
1501, and its variant, in which the target nucleoside was
‘ﬂipped out’ (i.e. rotated by 180 degrees). For all docking
targets, the low-resolution docking mode was used to
generate 1000 alternative orientations (poses) that
optimized the steric complementarity between the ligand
(Sgm) and the receptor (ribosome or its fragment). The
following parameters were used: energy scores for repul-
sion and attraction were 7 and –1, respectively, grid size
64A ˚ , grid step 6.8A ˚ . The ligand was rotated with
10 -angle intervals. Poses from each round of docking
were subsequently ranked according to the proximity
between the residues implicated in RNA binding to the
G1405 nucleoside, using the FILTREST3D server avail-
able at http://ﬁltrest3d.genesilico.pl (Michal J. Gajda and
J.M.B., manuscript in preparation). 100 top-scoring
models were clustered using MAXCLUSTER
(http://www.sbg.bio.ic.ac.uk/zmaxcluster/index.html),
and the central pose from the largest cluster was selected
as the representative model. The model of Sgm bound to
the 30S subunit in a mode that enables a contact with the
target base (i.e. with Sgm bound to the 30 minor domain)
was obtained by manual modiﬁcation of the 30S structure
with SwissPDBViewer (24).
Docking of the target guanosine to the Sgm crystal
structure was carried out with SURFLEX 1.31 (25). In
order to take into account the interactions of the
enzyme with the RNA backbone around the target, the
30 phosphate group was added to G1405, thus forming a
guanosine 30,50-bismonophosphate. The structure of that
ligand was prepared for docking with VegaZZ 2.2.0.54
(26). Several docking rounds with diﬀerent parameters
were performed. Each docking round started from 10
random orientations and conformations of the guanosine
bisphosphate. Additionally, 10 docking rounds with a
predeﬁned area of docking were performed. We rejected
all docking solutions, in which the methyl group acceptor,
i.e. the N
7 atom of guanosine, was >3A ˚ from the methyl
group of AdoMet. The remaining poses of the ligand were
ranked according to the crash and aﬃnity scores that
describe clashes of the ligand with the receptor molecule
as well as interactions within the ligand molecule, and
best-scoring poses were regarded as the most likely
models.
RESULTS
Overall structure
The structures of recombinant Sgm in complex with
AdoMet and AdoHcy were solved by MAD method (10)
from synchrotron data using SelMet labeled protein
(Table 1, Figure 1). Figure 2 shows the ﬁnal 2Fo-Fc
electron density map for Sgm–AdoMet and Sgm–
AdoHcy complexes. The ﬁrst seven residues, His-tag at
the N-terminal, and residues from Ser232 to Lys238
Figure 1. Structure of Sgm. Ribbon diagram of the Sgm–cofactor
complex monomer. The N and C termini are labeled. The NTD and
CTD domains of Sgm are colored in red and blue respectively with the
core secondary structures labeled. The cofactor AdoMet is depicted in
green. This ﬁgure and the following ﬁgures of this manuscript are
prepared by PyMol (44).
Nucleic Acids Research, 2010,Vol.38, No. 12 4123were not well deﬁned in the electron density map and were
not modeled. The asymmetric unit consists of a Sgm
complex molecule. This monomer observation is consis-
tent with the gel ﬁltration and dynamic light scattering
(DLS) experiments (data not shown).
As predicted earlier (9), Sgm is a two-domain protein,
comprising an N-terminal domain (NTD, Asp8–Pro70)
and a C-terminal domain (CTD, Asn71- Gln273). The
CTD adopts a typical Class I Rossmann-fold consisting
of a central seven stranded b sheet (b3"-b2"-
b1"-b4"-b5"-b7#-b6") surrounded by three a helices on
each side (27). At the N-terminus, this core of the CTD is
extended by two additional a-helices that are not
conserved in the RFM superfamily. The NTD is a
bundle of three a-helices with a left-handed twist,
exhibiting the RuvA CTD-like fold (Supplementary
Figure 1A). The active site is located in the CTD, which
interacts with the cofactors AdoMet and AdoHcy. The
superposition of these two complexes reveals a root
mean square deviation (RMSD) of 0.2A ˚ for 259 Ca
atoms. Both structures are nearly identical with negligi-
ble diﬀerences in the active-site region (Figure 2C).
The crystal structure reveals that the previously pub-
lished theoretical model (9) was accurate for the
homology-modeled RFM core (residues 111–267;
RMSD=2.32A ˚ ), however it has incorrectly predicted
the structure of the de novo-modeled N-terminal
extension.
Figure 2. Stereo view of the ﬁnal 2Fo-Fc electron density maps in the active-site region of Sgm. (A) Sgm–AdoMet complex. (B) Sgm–AdoHcy
complex. These maps are contoured at a level of 1s.( C) Stereo view of the superposition of Sgm–AdoMet and Sgm–AdoHcy complexes. AdoHcy is
shown in orange and AdoMet in green respectively.
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PDB performed with DALI (Table 2) revealed, as
expected, highest similarity to MTases from the Arm
family: RmtB (solved independently by Schmitt et al.
(28), PDB codes 3frh and 3fri and by the New York
Structural GenomiX Research Consortium
(NYSGXRC), PDB code 3b89, DOI 10.2210/pdb3b89/
pdb) and ArmA [(28) PDB code 3fzg]. It is important to
emphasize that these homologous MTases belong to a
small branch of the Arm family (proteins from patho-
gens), while the structure of Sgm presented herein is the
ﬁrst representative of the large subfamily (proteins from
antibiotic producers) (5,9). Sequences of Sgm and RmtB
(as well as Sgm and ArmA) exhibit 31% sequence identity
and their structures exhibit high structural similarity
(Supplementary Figure S1B). Subsequent matches in the
PDB are other RFM-fold proteins with predicted or deter-
mined methyltransferase activity: human adrenal gland
protein AD-003, and small RNA MTase HEN1. The sim-
ilarity between Sgm and all proteins except ArmA and
RmtB is limited to the RFM core of the CTD, and does
not include the additional two a-helices or the NTD.
Interestingly, other known structures of m
7G MTases
from the same RFM superfamily exhibited relatively low
DALI scores, indicating considerable structural
divergence.
DALI search for the isolated NTD structure revealed
similarity to ArmA methyltransferase (DALI Z-score 8.0,
RMSD=1.9A ˚ for 57 Ca atoms), but also to proteins
with the RuvA CTD-like fold, e.g. RuvA from
Mycobacterium tuberculosis (PDB code 2h5x; DALI
Z-score 7.0, RMSD=1.5A ˚ for 48 Ca atoms), and
NAD dependent malic enzyme (PDB code 1gz3; DALI
Z-score 5.5, RMSD=2.8A ˚ for 57 Ca atoms). NTD
also shows weak structural similarity to Ub-pathway
associated (UBA) and Ub-like (UBL) domains of
Ubiquitin-receptor proteins of the proteasome (PDB
code 2oob; DALI Z-score 4.9, RMSD=2.0A ˚ for 42 Ca
atoms). This domain is often involved in substrate recog-
nition, and is often found in proteins that bind nucleic
acids (e.g. RuvA or the elongation factor TFIIS). The
NTD of Sgm is highly basic (calculated pI=10.46)
compared with the CTD which is acidic (calculated
pI=5.57). Thus, it is tempting to speculate that the
NTD of Sgm is likely to dictate the substrate speciﬁcity
through the interactions with rRNA, to select the speciﬁc
region of 16S rRNA to be methylated.
Sgm–AdoMet/AdoHcy interactions
Residues such as His102, Ser104, Thr105, Arg108, Ala133,
Asp156, Asp182, Leu183, Leu198 and Gln207 line up the
cofactor-binding site of Sgm (Figure 2). These residues are
found to interact with the AdoMet and AdoHcy, and are
likely to play a key role in the methylation of G1405.
There are 11 hydrogen-bonding contacts (<3.2A ˚ )
between Sgm and AdoMet/AdoHcy. Leu183, Gln207
and the conserved Asp182 interact with the adenosine
moiety of the cofactors, whereas the conserved Asp156
coordinates the 20 and 30 hydroxyls of the ribose. Other
conserved residues such as Leu198, Ala133 and Arg108
interact with the carboxypropyl moiety of AdoMet/
AdoHcy.
Sequence conservation in Sgm and its homologs
Sequence analyses of Sgm revealed that it belongs to the
Arm family of MTases, which groups together 32
homologs [as of September 2009, a signiﬁcant expansion
from 19 members in our earlier study (9)]. Their hosts are
mainly antibiotic producers Streptomyces and
Micromonospora species, as well as pathogens. The
overall sequence identities between Sgm and its
homologs is over 30%. Supplementary Figure S2 shows
the multiple sequence alignment of all Arm sequences
detectable in databases. The CTD of Sgm has the nine
conserved motifs characteristic for the RFM superfamily
of MTases (29). In enzymes from this superfamily,
residues from motifs X, and I to IV typically interact
with the AdoMet molecule, and residues from motifs IV,
VI and VIII and sometimes X are usually involved in
Table 2. Structural matches of the Sgm protein, according to DALI (43): 10 most closely related protein structures, followed by three (very
remotely related) structures of other known m
7G MTases acting on diﬀerent RNA substrates
DALI match PDB id Z-score RMSD [A ˚ ] eq. residues seq.id. [%] Organism Protein
1 3frh 27.6 1.9 237 32 Escherichia coli RmtB
2 3fri 27.3 2.0 237 32 Escherichia coli RmtB
3 3b89 27.2 2.0 237 32 Escherichia coli RmtB
4 3fzg 20.2 2.5 188 31 Escherichia coli ArmA
5 2ex4 13.1 3.0 174 10 Homo sapiens Adrenal gland protein AD-003
6 1xtp 12.5 3.1 177 10 Leishmania major Hypothetical protein LMAJ004091AAA
7 3jwh 12.5 2.9 156 15 Anabaena variabilis Small RNA MTase HEN1
8 3jwj 12.5 3.0 158 15 Anabaena variabilis Small RNA MTase HEN1
9 3jwi 12.4 3.0 157 13 Clostridium thermocellum Small RNA MTase HEN1
10 1ve3 12.3 3.1 168 13 Pyrococcus horikoshii Hypothetical protein PH0226
(...)
165 1ri2 10.6 3.1 156 13 Encephalitozooon cuniculi mRNA cap 0 MTase Ecm1
304 1jsx 9.7 3.4 150 11 Escherichia coli 23S rRNA m
7G1835 MTase RsmG
454 2fca 8.1 3.4 132 8 Bacillus subtilis tRNA m
7G46 MTase TrmB
Only the best superimposed protein chain per individual structure has been included. Strongest structural and sequence similarities to the Arm family
members are shown in bold.
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poorly conserved and include residues important for the
stability of the RFM fold. The structures of Sgm–AdoHcy
and Sgm–AdoMet complexes presented here reveal the
exact role of individual residues. Interestingly, in our
searches we identiﬁed new, strongly diverged members of
the Arm family from N. equitans (NEQ545, the ﬁrst
archaeal ortholog) and C. thermocellum (Cthe3180).
While they exhibit perfect conservation of motifs in the
C-terminal catalytic domain, their NTDs appear to be
strongly diverged in sequence. Computational structure
predictions (secondary structure prediction as well as
protein fold-recognition, see Matrials and methods
section) suggest that these diverged N-terminal regions
also exhibit propensity to fold into helical structures
similar to those observed in Sgm, ArmA and RmtB
MTases. However, the NEQ545 sequence lacks one helix
and the Cthe3180 sequence appears to possess one addi-
tional helix. It is unclear if these two proteins exhibit the
same function as orthodox members of the Arm family,
nonetheless they should be classiﬁed as Arm members
in the evolutionary sense. Phylogenetic analysis
(Supplementary Figure S3) conﬁrms that NEQ545 and
Cthe3180 are the most diverged members of the Arm
family and shows that they have originated from the
group of MTases from pathogens, rather than those
from antibiotic producers.
ITC analyses
Interactions between Sgm with both cofactors were
studied by isothermal titration calorimetry (ITC)
(Figure 3, Supplementary Figure S4). The dissociation
constant (Kd) for AdoMet was determined to be 18mM
with N=0.90, which is consistent with the results
obtained by Savic et al. (30) for Sgm and AdoMet. The
dissociation constant (Kd) for AdoHcy, which was not
reported before, is 300mM with N=1.0. We have per-
formed the ITC experiments on the mutants D156A,
D182A and R108A with both AdoMet and AdoHcy
using the same conditions as the native Sgm with
cofactors. A complete loss of binding was observed
when the Sgm mutants D156A, D182A or R108A were
titrated against both AdoMet and AdoHcy (Figure 3,
Supplementary Figure S4). Interaction between Sgm and
guanine nucleotide was also studied by ITC. Guanosine
50-monophosphate was used because guanosine did not
solubilize in the buﬀer used. The dissociation constant
(Kd) was determined to be 1.4mM with N=1.1. The
low aﬃnity suggests that Sgm requires contacts with the
RNA ﬂanking the guanosine moiety.
RNA footprinting analysis of Sgm interactions with the
30S subunit
Sgm has been found to act on fully assembled 30S
ribosomal subunit (SSU) (4). Chemical footprinting with
CMCT and DEPC was carried out on E. coli 30S subunits
to determine the sites of Sgm–ribosome interaction. After
incubation with Sgm and chemical modiﬁcation with
CMCT (speciﬁc for nucleotides G and U) and DEPC
(speciﬁc for nucleotide A) we screened with primer
extension from diﬀerent parts of 16S rRNA that are spa-
tially close to G1405, the target of Sgm methylation
(Supplementary Figure S5, Figure 4). Despite our eﬀorts
to analyze entire helix 44 (nt 1404–1497) with a primer
used previously by Kaberdina et al. (31), in our hands
this primer could not be properly extended. Using
primer 1459–1479 we were therefore able to detect
changes only in one strand of helix 44, starting with
U1450, down to C1302 in helix 42. We have also used
primers 939–955 and 817–833. Nucleotides found to be
protected in the presence of Sgm included A694, A695,
A718, G734, G733, U751, G755, U757, G765, A790,
U793, U798, G887, G895, G1387, G1401, G1405 (the
methylatable target), U1414, G1423, G1426, G1435,
U1445 and U1450. At the same time nt G774, G775,
G776, G1323, U1341, U1358, U1376, C1393, A1394,
C1407, A1408, C1412, A1413, U1436, U1440 and U1444
were found to be deprotected in the presence of Sgm. This
suggests that a conformational changes occur in the SSU
upon its interactions with Sgm that allow the enzyme to
access the target nucleotide G1405, which is otherwise
buried in the crystal structure of 30S subunit.
Modeling of Sgm-substrate complex
To gain insight into the possible mechanism of Sgm–
target-base interactions, we used a high-resolution-
docking method SurFlex in order to position G1405 (in
the form of a 3050-bismonophosphate) into the active site
of the Sgm–AdoMet complex (see ‘Materials and
Methods’ section). The ligand was treated as a ﬂexible
molecule, while the receptor (Sgm–AdoMet complex)
was kept rigid. The best pose [score: aﬃnity 6.03, crash
–1.25 (self –0.37)] was found to ﬁt very well into the Sgm
active site, without any large conformational changes of
the protein (Figure 5). According to the docking model,
the methyl group of K199 from motif IV may interact with
the O
6 atom of the base. This residue potentially assisted
by the hydroxyl group of S104, and most likely positions
guanosine in appropriate orientation with respect to the
methyl group donor. F64 from the NTD and P229 from
motif VI form the walls of the guanosine-binding pocket
and are likely to be important for the stable binding of the
target base in the active site. Other possible interactions
include hydrogen-bonding between E107 with the N
2 and
possibly also N
1 atoms of the target base (if the side chain
of E107 undergoes appropriate reorientation). The
hydroxyl groups of T206 and Y244 may coordinate
either of the phosphate groups.
In order to predict the mode of protein-substrate inter-
actions, we attempted to dock the Sgm–AdoMet complex
to the 30S subunit structure, with a restraint imposed as to
minimize the distance between the methyl group of
AdoMet and the target nucleoside G1405 (see ‘Materials
and methods’ section for details). In all docking solutions,
the protein could reach only the solvent-exposed face of
the helix, and no models could be obtained with the target
base closer than 15A ˚ to the methyl group of AdoMet.
This macromolecular docking analysis indicates that
Sgm cannot access G1405 while the 30S subunit is in the
crystal-like conformation and, in agreement with our
4126 Nucleic Acids Research, 2010,Vol.38, No. 12Figure 3. ITC analyses. (A) Sgm–AdoHcy titration. (B) Sgm mutant R108A-AdoMet titration. (C) Sgm–GMP titration. The upper panels show the
injection proﬁle after baseline correction and the bottom panels show the integration (heat release) for each injection (except the ﬁrst one).
Nucleic Acids Research, 2010,Vol.38, No. 12 4127Figure 4. Schematic presentation of the Sgm–30S ribosomal subunit complex. (A) Summary of the footprinting results. Sections of the 16S rRNA
that were analyzed by primer extension are shaded in grey. Nucleotides protected upon Sgm binding are indicated with a black dot, whereas exposed
nucleotides are indicated with a black triangle symbol. For circle indicated regions, structural change was observed upon Sgm binding to 30S
subunits. Helix numbering is presented in boxes. After chemical footprint, rRNA was extended with reverse transcriptase with primers complemen-
tary to regions: (1) 817–833, (2) 939–955 and (3) 1459–1479. (B) Mapping of footprinting data onto the 30S structure. Components of the 30S
subunit are shown in the surface representation, ribosomal proteins are indicated in dark gray, 16S rRNA is indicated in light gray with the exception
of helix 44 (residues 1400–1499), shown in white. Results of the footprinting experiments are color coded as follows: residues relatively more reactive
in the footprinting experiment are shown in green, residues less reactive in the footprinting experiment are shown in red. The target G1405 is shown
in yellow and is additionally indicated by a yellow circle. (C) Extreme steric clashes between Sgm and the 30S subunit occur, if the enzyme is docked
to its target in helix 44 without any conformational changes. The 30S structure is color-coded as in panel B, but semi-transparent. Sgm is shown as a
solid ribbon in blue; target G1405 is shown in yellow and helix 44 is shown in white.
4128 Nucleic Acids Research, 2010,Vol.38, No. 12RNA footprinting results, suggests that a conformational
rearrangement must occur to expose G1405 and enable
methylation. Interestingly, docking of Sgm to helix 44
detached from the rest of the 30S subunit has led to a
model with the protein active site close to the target
nucleoside G1405. In this position, the target base could
be positioned within the active site of Sgm by simply
rotating it out of the helix (Supplementary Figure 6).
Base ﬂipping has been documented for both DNA- and
RNA-modifying enzymes and is believed to be the
dominant mechanism used by these enzymes to access
target bases that are normally non-accessible due to sec-
ondary and/or tertiary interactions in the nucleic-acid
molecule (32). The orientation of the base ﬂipped out of
docked helix 44 is essentially identical to that obtained by
docking of 3050-bismonophosphate. This suggests that
both docking simulations produced the geometrically
most reasonable solution for the problem of protein–
target interactions.
DISCUSSION
Conservation of sequence, structure and function in the
Arm family
Sgm belongs to the Arm family, whose members
methylate the N
7 atom of G1405 in bacterial 16S rRNA,
thereby conferring resistance to aminoglycoside antibi-
otics. Previous analyses established that Arm MTases
are composed of two domains, with the large C-terminal
RFM-fold domain responsible for cofactor binding and
catalysis, and the small NTD most likely involved in
RNA binding (9,28). According to phylogenetic
analyses, the Arm family can be subdivided into two
subfamilies, a large one represented by presumably ances-
tral MTases from antibiotic producers (e.g. Sgm and
KgmB), and a smaller one with MTases that have been
acquired by pathogenic bacteria via horizontal gene
transfer (e.g. ArmA and RmtB) (5,9). Thus far, crystal
structures have been determined only for ArmA and
RmtB, members of the small subfamily (28). We have
determined the ﬁrst structure of an Arm enzyme from
an antibiotic producer, a representative of the large sub-
family, which provides evidence for a common architec-
ture and close evolutionary relationship between both
types of MTases.
The Sgm complex structures with AdoMet and AdoHcy
highlighted the importance of the residues R108, G135 (in
motif I), D156 (in motif II) and D182 (in motif III) as
crucial for the interaction of Sgm with the cofactors.
D156 and D182 were previously shown to be indispens-
able for rendering bacteria resistant to kanamycin and
gentamicin (9,30) and their role in AdoMet binding was
conﬁrmed by ITC (30). Residues homologous to D156
and D182 are functionally conserved in Rossmann-fold
MTases and form hydrogen bonds with the cofactors.
As anticipated, mutation of D156A, D182A or R108A
disrupted the binding, as determined by the ITC titrations.
It is worth mentioning here that these three residues alone
provide at least ﬁve H-bonding contacts with AdoMet/
AdoHcy. Therefore, we conclude that these three
residues play a crucial role in the catalytic activity of the
Sgm and the mutation of any one of them abolishes the
binding of the cofactors. Structural similarity between
Arm MTases from pathogens and antibiotic producers
and evolutionary conservation of residues predicted to
be involved in substrate binding strongly suggest that
the mode of enzyme–substrate interactions is conserved
in both types of MTases.
Our analysis also provides the ﬁrst characterization of
interactions between an Arm family MTase and its
substrate, the 30S subunit. We have analyzed the RNA–
Sgm contacts in detail by chemical probing following by
primer extensions. Figure 4B shows the results of RNA
footprinting mapped onto the crystal structure of the 30S
subunit. The target nucleoside G1405 is base-paired with
C1496 at the base of long helix 44 formed by the 30 minor
domain of 16S rRNA, buried in the structure, and its N
7
atom is not accessible for methylation, hence
a conformational change must occur in order for the
methylation to take place (Figure 4C). This is supported
both by observations that short CA stretches upstream
and downstream of G1405 show increased reactivity in
the presence of Sgm. Interestingly, changes in propensity
of 16S rRNA residues to react with hydroxyl radicals
upon interaction with Sgm are not localized exclusively
to the region surrounding the target guanine residue, but
are scattered around diﬀerent parts of the 30S subunit,
both in sequence and in space. Both the results of
footprinting and docking analyses suggest that the
Figure 5. Model of guanosine 3050-bismonophosphate docked to the
Sgm–AdoMet complex. Residues 1–63 have been omitted for clarity.
The protein backbone is shown as a ribbon (with helices in violet and
strands in yellow). Residues predicted to interact with the target
nucleoside are shown as sticks and labeled; contacts predicted in
detail are shown as green broken lines. A contact between the
transferrable methyl group and the target N
7 atom (distance=3A ˚ )i s
shown by a red arrow.
Nucleic Acids Research, 2010,Vol.38, No. 12 4129conformational change of the 30S subunit upon Sgm
binding involves the rearrangement of helix 44,
and most likely base-ﬂipping of G1405. However,
we were unable to build a model of a 30S–Sgm complex
that would satisfactorily explain all our footprinting data.
Hence, conformational changes that are expected to
occur in 16S rRNA upon Sgm binding are most likely
complex and involve multiple rearrangements of spa-
tially distant elements that probably have a global
character.
Convergence of catalytic mechanisms among diﬀerent
m
7G MTases from the same RFM superfamily
Based on sequence analyses and comparison of conserved
residues in active sites of m
7G MTases from various
families it has been postulated that they may bind the
target base in diﬀerent ways (33,34). However, thus far
the structure-based model of MTase–AdoMet–guanosine
interactions has been available only for cap 0 MTases that
modify G0 in eukaryotic mRNA (35). In addition to the
Arm family of 16S rRNA:m
7G1405 MTases analyzed in
this work, crystal structures are available for representa-
tives of the tRNA:m7G46 (TrmB) MTase family (36) and
16S rRNA:m
7G527 (RsmG) MTase family [previously
known as GidB (37)]. A molecular model has been also
proposed for the Bud23 protein, a representative of a
family of eukaryotic MTases involved in m
7G1575 modi-
ﬁcation in 18S rRNA (38). However, none of these struc-
tures have been solved with the substrate, and the details
of protein-guanosine contacts and the mechanism(s) of
action remain unknown.
We constructed models of protein–AdoMet complexes
(by copying the coordinates of AdoMet from
homologous structures) and carried out guanosine
3050-monobisphosphate docking for TrmB from Bacillus
subtilis (PDB code: 2fca), and RsmG from E. coli(PDB
code: 1jsx), as described in Materials and methods section.
Figure 6 illustrates the experimentally determined orienta-
tion of both ligands in the cocrystal structures of cap 0
MTase Ecm1 from Encephalitozoon cuniculi [a combina-
tion of Ecm1–AdoMet and Ecm1–m
7Gppp complexes,
PDB codes 1ri2 and 1ri4 (35)] and the predicted orienta-
tion of ligands in docking models constructed here for
Sgm, TrmB and RsmG. We have also mapped sequence
conservation in each respective protein family onto the
representative structures and identiﬁed the potential key
ligand-binding residues (Table 3). In the comparative
sequence analysis we have also included the model of
Bud32, whose accuracy is insuﬃcient for high-resolution
docking, but allows for prediction of potential catalytic
residues.
The docking analysis and sequence conservation
mapping reveal that both the cofactor-binding residues
(in particular the three acidic residues coordinating
the methionine, ribose and adenosine moieties of
AdoMet) and the cofactor-binding mode are conserved
among all m
7G MTases included in this study
(the only exception is the lack of carboxylate residue in
motif III of RsmG). On the other hand, the target
guanosine-binding residues are quite diﬀerent between
all proteins, and likewise, the (predicted) conformation
and orientation of the docked guanosine varies greatly.
Although there are analogies in the type of amino acids
that interact with the target guanosine (e.g. the
use of Pro, Tyr, or Phe to stabilize the base), their
position is typically non-homologous, and the 3D
Figure 6. Orientation of AdoMet and guanosine in m
7G MTases Ecm1 (position of AdoMet and guanosine determined experimentally), Sgm
(docked guanosine), TrmB (docked AdoMet and guanosine) and RsmG (docked guanosine). Both ligand and the substrate have been presented
in wireframe representation. Green structures correspond to positions occupied in Sgm, cyan in TrmB, magenta in RsmG and grey in Ecm1. On the
left panel (A) the methyl group of AdoMet is indicated by a hashed circle, while on the right panel (B) it is not shown explicitly, instead its position is
indicated by a red cross. The target N
7 atom of guanosine in diﬀerent complexes is indicated by a semi-transparent circle in the same color as the
nucleoside.
4130 Nucleic Acids Research, 2010,Vol.38, No. 12arrangements are completely diﬀerent, demonstrating
alternative solutions for the methylation of the N
7 atom
of guanine.
Our docking models suggest that at least four diﬀerent
m
7G MTase families evolved independent ways
of recognizing the target guanosine. This is in agreement
with the results of our phylogenetic analysis of the
entire RFM superfamily, in which the aforementioned
families of m
7G MTases do not form a single branch on
the tree and most likely have evolved independently
(K.L.T. and J.M.B., unpublished data). This situation
resembles the polyphyletic evolution of 20-O-ribose
MTases, which are known to belong to diﬀerent folds,
SPOUT (39) and RFM (40), and even within the
RFM-fold exhibit several diﬀerent architectures of the
active site (41).
The ﬁnding that other m
7G MTases [especially the cap 0
MTase that is essential for the human cells (42)] exhibit dif-
ferent modes of protein–ligand interactions, suggests that
Arm-speciﬁcinhibitorscanbedevelopedthatwillnotinter-
fere with other physiologically important m
7G
methylations. Thus, the results of our analyses provide a
stepping stone for the design of inhibitors against the
medically important Arm family of MTases. In particular,
the guanosine-binding site identiﬁed in the Sgm struc-
ture (and by extension, in homologous structures of
ArmA and RmtB MTases) can be used as receptor
for structure-based virtual screening.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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